Personal Health  
comments_image Comments

6 New Ways Big Pharma Is Scheming to Make Billions at the Expense of Your Health

With many of Big Pharma's biggest hits going off patent, the industry is looking for new ways to deliver earnings to Wall Street.
 
 
Share
 
 
 
 

The blockbuster pill profit party is over for Big Pharma. Bestselling pills like Lipitor, Seroquel, Zyprexa, Singular and Concerta have gone off patent and sites which their ads sustained are withering on the vine. WebMD, for example, the voice of Pharma on the Web, with a former  Pfizer exec serving as CEO, announced it would cut  250 positions in December.

But don't worry, Wall Street. Pharma isn't going to deliver disappointing earnings just because it has little or no new drugs coming online and has failed at the very reason for its existence. Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones.

1) Repurposing Ritalin

Now that Pharma's succeeded in getting  five million children and four to  eight million adults diagnosed with ADHD, it's looking for new markets for the drugs. One new use for Ritalin (methylphenidate), the grandfather of ADHD drugs, could be for eating disorders . Researchers say a woman who suffered from bulimia nervosa, bipolar I disorder, cocaine and alcohol dependence, attention-deficit hyperactivity disorder and panic disorder "achieved a sustained (>1 year) remission" when methylphenidate was added to her other drugs.

Then there's pregnant women. A new paper suggests that taking away a women's methylphenidate during pregnancy may  "may present a significant risk" and that, "In all cases, children developed normally and no adverse effects were reported," though they were exposed in utero. Yes, kids can be given ADHD meds at even younger ages--as fetuses.

Pharma is also looking at the elderly as a new market for ADHD drugs. Methylphenidate may "improve gait function in older adults,"  researchers wrote recently. And a major clinical trial sponsored by Johns Hopkins Bloomberg School of Public Health is  underway to see if methylphenidate can reduce apathy in Alzheimer patients. Of course many Alzheimer patients don't have apathy but agitation and aggression; they will be excluded.

2) Male Hormone Replacement

Women over 40 might feel a rush of medical justice over the big push to treat men's "Low T," a recent "disease" now aggressively marketed, with replacement testosterone. For over 50 years, medical journals were relentless in telling women they were "outliving their ovaries" (a real ad) and the only hope to keep their looks, their husbands and their sanity was hormone replacement. Now men are hearing that their decreased sex drive and energy, reduced muscle and growing fat put them in the same position. Missing in both marketing campaigns is the fact that people don't get old because they lose hormones; they lose hormones because they get old.

Many testosterone replacement products have been  approved by the FDA from pills, injections and patches to gels and solutions that are applied topically. In November, the first underarm testosterone replacement product was approved which is applied like deodorant.

The male HRT products are not without their  risks. They can worsen benign prostate problems, heart failure, sleep apnea, cause liver toxicity and possibly stimulate prostate cancer though it remains a theoretical risk. Injected testosterone has been  associated with embolisms and extreme allergic reactions (anaphylaxis) both of which can be fatal. Men who take  Propecia for hair loss can especially have low testosterone, which may not be reversible, because it reduces an enzyme involved in testosterone synthesis.

3) Calling Alcoholics and Addicts Mentally Ill and In Need of Vaccines

One of the few good things about alcoholism and drug addiction is they can be treated for free. Twelve-step programs like Alcoholics Anonymous use peer support instead of drugs, trained personnel or insurance -- and they work. It's no surprise that the millions of people recovering without Pharma's help are its latest target as it tries to shore up revenues. Pharma is increasingly pressuring rehab facilities and doctors to add a mental illness diagnoses to recovering patients to sell expensive pills. Ka-ching!

 
See more stories tagged with: